Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Karrasch

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
European Journal of Nuclear Medicine and Molecular Imaging|September 28, 2013
Five-year follow-up of 11C-PIB uptake in Alzheimer's disease and MCIN M Kemppainen, N M Scheinin, J Koivunen, et al.
Neurology|September 4, 2009
Follow-up of [11C]PIB uptake and brain volume in patients with Alzheimer disease and controlsN M Scheinin, S Aalto, J Koikkalainen, et al.
Scientific Reports|October 14, 2020
Deep amoA amplicon sequencing reveals community partitioning within ammonia-oxidizing bacteria in the environmentally dynamic estuary of the River ElbeM Malinowski, M Alawi, I Krohn, et al.
Annals of Hematology|April 1, 2014
Clofarabine in combination with a standard remission induction regimen (cytosine arabinoside and idarubicin) in patients with previously untreated intermediate and bad-risk acute myelogenous leukemia (AML) or high-risk myelodysplastic syndrome (HR-MDS): phase I results of an ongoing phase I/II study of the leukemia groups of EORTC and GIMEMA (EORTC GIMEMA 06061/AML-14A trial)R Willemze, S Suciu, P Muus, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
European Journal of Nuclear Medicine and Molecular Imaging|September 28, 2013
Five-year follow-up of 11C-PIB uptake in Alzheimer's disease and MCIN M Kemppainen, N M Scheinin, J Koivunen, et al.
Neurology|September 4, 2009
Follow-up of [11C]PIB uptake and brain volume in patients with Alzheimer disease and controlsN M Scheinin, S Aalto, J Koikkalainen, et al.
Scientific Reports|October 14, 2020
Deep amoA amplicon sequencing reveals community partitioning within ammonia-oxidizing bacteria in the environmentally dynamic estuary of the River ElbeM Malinowski, M Alawi, I Krohn, et al.
Annals of Hematology|April 1, 2014
Clofarabine in combination with a standard remission induction regimen (cytosine arabinoside and idarubicin) in patients with previously untreated intermediate and bad-risk acute myelogenous leukemia (AML) or high-risk myelodysplastic syndrome (HR-MDS): phase I results of an ongoing phase I/II study of the leukemia groups of EORTC and GIMEMA (EORTC GIMEMA 06061/AML-14A trial)R Willemze, S Suciu, P Muus, et al.
Pageof 3